Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Frédéric Rieux‐Laucat(Inserm), Jean‐Pierre de Villartay(Université Paris Cité), Irene Roberts(Hammersmith Hospital), Claire Hivroz(Inserm), Françoise Le Deist(Centre National de la Recherche Scientifique), Klaus‐Michael Debatin(German Centre for Cardiovascular Research), Alain Fischer(Inserm)
Cited by 1,297
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k